Literature DB >> 16444920

Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease.

Robert J Fox1, Francois Bethoux, Myla D Goldman, Jeffrey A Cohen.   

Abstract

Recent advances in our understanding of the diagnosis, imaging, pathology, and clinical monitoring of multiple sclerosis (MS) have significantly increased our ability to successfully treat this often perplexing neurologic disorder. Magnetic resonance imaging (MRI) is now integral to the diagnostic process. Treatment of MS can be considered as three parallel pathways: treatment of relapses, symptom management, and long-term prevention of tissue injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444920     DOI: 10.3949/ccjm.73.1.91

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  13 in total

1.  The role of chromogranin B in an animal model of multiple sclerosis.

Authors:  Michelle Mo; Ha Thi Hoang; Stefan Schmidt; Robert B Clark; Barbara E Ehrlich
Journal:  Mol Cell Neurosci       Date:  2013-04-24       Impact factor: 4.314

2.  Glucose uptake heterogeneity of the leg muscles is similar between patients with multiple sclerosis and healthy controls during walking.

Authors:  John H Kindred; Nathaniel B Ketelhut; Thorsten Rudroff
Journal:  Clin Biomech (Bristol, Avon)       Date:  2014-12-17       Impact factor: 2.063

3.  Use of cognitive aids and other assistive technology by individuals with multiple sclerosis.

Authors:  Kurt L Johnson; Alyssa M Bamer; Kathryn M Yorkston; Dagmar Amtmann
Journal:  Disabil Rehabil Assist Technol       Date:  2009-01

4.  Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients.

Authors:  Roselia Maria Spanevello; Cinthia Melazzo Mazzanti; Margarete Bagatini; Maisa Correa; Roberta Schmatz; Naiara Stefanello; Gustavo Thomé; Vera Maria Morsch; Lara Becker; Luziane Bellé; Liliane de Oliveira; Maria Rosa Chitolina Schetinger
Journal:  J Neurol       Date:  2009-07-24       Impact factor: 4.849

Review 5.  Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

Authors:  Violaine K Harris; Saud A Sadiq
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

6.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04

Review 7.  Can tetracyclines ensure help in multiple sclerosis immunotherapy?

Authors:  Pedro Víctor-Carvalho; Rodolfo Thome; Catarina Rapôso
Journal:  J Clin Transl Res       Date:  2021-02-03

8.  Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).

Authors:  Paul Wicks; Michael Massagli; Amit Kulkarni; Homa Dastani
Journal:  J Med Internet Res       Date:  2011-01-24       Impact factor: 5.428

9.  Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple Sclerosis.

Authors:  John H Kindred; Jetro J Tuulari; Marco Bucci; Kari K Kalliokoski; Thorsten Rudroff
Journal:  Front Hum Neurosci       Date:  2015-02-18       Impact factor: 3.169

Review 10.  Spasticity in multiple sclerosis and role of glatiramer acetate treatment.

Authors:  Jose Eustasio Meca-Lallana; Rocío Hernández-Clares; Ester Carreón-Guarnizo
Journal:  Brain Behav       Date:  2015-07-14       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.